173 related articles for article (PubMed ID: 3332164)
21. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
[TBL] [Abstract][Full Text] [Related]
22. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
23. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC
Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
[TBL] [Abstract][Full Text] [Related]
24. High dose therapy and autologous bone marrow versus blood cell rescue. South Island Bone Marrow Transplant Unit.
Hill GR; Inder A; Patton WN; Hart DN
N Z Med J; 1996 Feb; 109(1016):45-8. PubMed ID: 8598936
[TBL] [Abstract][Full Text] [Related]
25. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
26. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
27. The ex vivo expansion of feline marrow cells leads to increased numbers of BFU-E and CFU-GM but a loss of reconstituting ability.
Abkowitz JL; Taboada MR; Sabo KM; Shelton GH
Stem Cells; 1998; 16(4):288-93. PubMed ID: 9708451
[TBL] [Abstract][Full Text] [Related]
28. Special Education.
Kozutsumi H
Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates.
Gallicchio VS; Casale GP; Watts T
Exp Hematol; 1987 Dec; 15(11):1099-102. PubMed ID: 3678410
[TBL] [Abstract][Full Text] [Related]
30. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC
Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
[TBL] [Abstract][Full Text] [Related]
31. Morphology of cells grown in the CFU-GEMM tissue culture assay from mononuclear cells obtained from peripheral blood and bone marrow of normal volunteers.
O'Murchadha ET; Horland A; Neiman RS; Valeri CR
Exp Hematol; 1988 Mar; 16(3):235-9. PubMed ID: 3338518
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E.
Lu L; Pelus LM; Broxmeyer HE
Exp Hematol; 1984 Oct; 12(9):741-8. PubMed ID: 6436046
[TBL] [Abstract][Full Text] [Related]
33. Megakaryocytic differentiation capacity of human pluripotent bone marrow progenitor cells CFU-GEMM in vitro after cryopreservation.
Ganser A; Hoelzer D
Scand J Haematol; 1985 Oct; 35(4):418-22. PubMed ID: 4081641
[TBL] [Abstract][Full Text] [Related]
34. Erythroid burst-forming units (BFU-E) predict hematopoietic recovery after peripheral blood progenitor cell transplantation in patients with advanced breast cancer.
Cooper BW; Mackay W; Gerson SL; Lazarus HM
Bone Marrow Transplant; 1997 Jun; 19(11):1089-94. PubMed ID: 9193751
[TBL] [Abstract][Full Text] [Related]
35. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
36. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
[TBL] [Abstract][Full Text] [Related]
37. Influence of different temperature of cryopreservation on the proliferative potential of human bone marrow progenitor cells. Transplantological implications.
Ratajczak MZ; Kuczyński WI; Ratajczak J
Arch Immunol Ther Exp (Warsz); 1994; 42(3):217-21. PubMed ID: 7487356
[TBL] [Abstract][Full Text] [Related]
38. Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamide.
Rowley SD; Colvin OM; Stuart RK
Exp Hematol; 1985 May; 13(4):295-8. PubMed ID: 3987832
[TBL] [Abstract][Full Text] [Related]
39. Expression of Friend leukemia virus and spleen focus-forming virus-specific sequences in erythroid bursts and granulocyte-macrophage colonies from spleen and marrow of mice infected with Friend leukemia virus.
Colletta G; Di Fiore PP; Fusco A; Lettieri F; Covelli A; Peschle C
Cancer Res; 1983 Feb; 43(2):598-603. PubMed ID: 6293700
[TBL] [Abstract][Full Text] [Related]
40. Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow.
Laterveer L; van Damme J; Willemze R; Fibbe WE
Exp Hematol; 1993 Dec; 21(13):1621-7. PubMed ID: 8243564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
